Isolated Diastolic Hypertension in the IDACO Study: An Age-Stratified Analysis Using 24-Hour Ambulatory Blood Pressure Measurements
John W. McEvoy,Wen-Yi Yang,Lutgarde Thijs,Zhen-Yu Zhang,Jesus D. Melgarejo,José Boggia,Tine W. Hansen,Kei Asayama,Takayoshi Ohkubo,Eamon Dolan,Katarzyna Stolarz-Skrzypek,Sofia Malyutina,Edoardo Casiglia,Lars Lind,Jan Filipovský,Gladys E. Maestre,Yan Li,Ji-Guang Wang,Yutaka Imai,Kalina Kawecka-Jaszcz,Edgardo Sandoya,Krzysztof Narkiewicz,Eoin O’Brien,Thomas Vanassche,Jan A. Staessen,John W. McEvoyWen-Yi YangLutgarde ThijsZhen-Yu ZhangJesus D. MelgarejoJosé BoggiaTine W. HansenKei AsayamaTakayoshi OhkuboEamon DolanKatarzyna Stolarz-SkrzypekSofia MalyutinaEdoardo CasigliaLars LindJan FilipovskýGladys E. MaestreYan LiJi-Guang WangYutaka ImaiKalina Kawecka-JaszczEdgardo SandoyaKrzysztof NarkiewiczEoin O'BrienThomas VanasscheJan A. StaessenNational University of Ireland Galway,School of Medicine,and National Institute for Prevention and Cardiovascular Health,Ireland (J.W.M.).Department of Cardiology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,China.(W.-Y.Y.)Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation,Shanghai Institute of Hypertension,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,China. (Y.L.,J.-G.W.)Research Unit Hypertension and Cardiovascular Epidemiology,KU Leuven Department of Cardiovascular Sciences,University of Leuven,Belgium. (Z.-Y.Z.,L.T.,J.D.M.,K.A.)Centre for Molecular and Vascular Biology,KU Leuven Department of Cardiovascular Sciences,University of Leuven,Belgium. (T.V.)Biomedical Sciences Group,Faculty of Medicine,University of Leuven,Belgium. (J.A.S.)Centro de Nefrología and Departamento de Fisiopatología,Hospital de Clínicas,Universidad de la República,Montevideo,Uruguay (J.B.).The Steno Diabetes Center Copenhagen,Gentofte,and Center for Health,Capital Region of Denmark,Copenhagen (T.W.H.).Tohoku Institute for Management of Blood Pressure,Sendai,Japan (K.A.,T.O.,Y.I.).Department of Hygiene and Public Health,Teikyo University School of Medicine,Tokyo,Japan (K.A.,T.O.).Stroke and Hypertension Unit,Connolly Hospital,Geriatric Medicine,Dublin,Ireland (E.D.).The First Department of Cardiology,Interventional Electrocardiology and Hypertension,Jagiellonian University Medical College,Krakow,Poland (K.S.-S.,K.K.-J.).Institute of Internal and Preventive Medicine and Institute of Cytology and Genetics,Siberian Branch of the Russian Academy of Sciences,Novosibirsk,Russian Federation (S.M.).Department of Medicine,University of Padua,Italy (E.C.).Section of Geriatrics,Department of Public Health and Caring Sciences,Uppsala University,Sweden (L.L.).Faculty of Medicine,Charles University,Pilsen,Czech Republic (J.F.).Laboratorio de Neurociencias and Instituto Cardiovascular,Universidad del Zulia,Maracaibo,Venezuela (G.E.M.).Department of Biomedical Sciences,Division of Neuroscience and Department of Human Genetics,University of Texas Rio Grande Valley School of Medicine,Brownsville (G.E.M.).Asociación Española Primera de Socorros Mutuos,Montevideo,Uruguay (E.S.).Hypertension Unit,Department of Hypertension and Diabetology,Medical University of Gdansk,Poland (K.N.).Conway Institute of Biomolecular and Biomedical Research,University College Dublin,Ireland (E.O.).Research Institute Alliance for the Promotion of Preventive Medicine,Mecehelen,Belgium (J.A.S).
DOI: https://doi.org/10.1161/hypertensionaha.121.17766
IF: 9.8968
2021-10-04
Hypertension
Abstract:The prognostic implications of isolated diastolic hypertension (IDH), as defined by 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines, have not been tested using ambulatory blood pressure (BP) monitor thresholds (ie, 24-hour mean systolic BP <125 mm Hg and diastolic BP ≥75 mm Hg). We analyzed data from 11 135 participants in the IDACO (International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes). Using 24-hour mean ambulatory BP monitor values, we performed Cox regression testing independent associations of IDH with death or cardiovascular events. Analyses were conducted in the cohort overall, as well as after age stratification (<50 years versus ≥50 years). The median age at baseline was 54.7 years and 49% were female. Over a median follow-up of 13.8 years, 2836 participants died, and 2049 experienced a cardiovascular event. Overall, irrespective of age, IDH on 24-hour ambulatory BP monitor defined by 2017 American College of Cardiology/American Heart Association criteria was not significantly associated with death (hazard ratio, 0.95 [95% CI, 0.79–1.13]) or cardiovascular events (hazard ratio, 1.14 [95% CI, 0.94–1.40]), compared with normotension. However, among the subgroup <50 years old, IDH was associated with excess risk for cardiovascular events (2.87 [95% CI, 1.72–4.80]), with evidence for effect modification based on age ( P interaction <0.001). In conclusion, using ambulatory BP monitor data, this study suggests that IDH defined by 2017 American College of Cardiology/American Heart Association criteria is not a risk factor for cardiovascular disease in adults aged 50 years or older but is a risk factor among younger adults. Thus, age is an important consideration in the clinical management of adults with IDH.
peripheral vascular disease